Sale!

KDM6A Gene Kabuki syndrome type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KDM6A gene is associated with Kabuki syndrome type 2, a rare genetic disorder characterized by distinctive facial features, growth delays, intellectual disability, and various organ anomalies. Genetic testing for mutations in the KDM6A gene can confirm a diagnosis of Kabuki syndrome type 2, aiding in the management and treatment of the condition. At DNA Labs UAE, a specialized test is available to analyze the KDM6A gene for mutations linked to this syndrome. The cost of the test is 4400 AED. This precise genetic testing provides critical information for families and healthcare providers, facilitating personalized care plans and interventions for affected individuals.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KDM6A Gene Kabuki Syndrome Type 2 Genetic Test

At DNA Labs UAE, we offer the KDM6A Gene Kabuki Syndrome Type 2 Genetic Test for individuals suspected of having this rare genetic disorder. Kabuki syndrome type 2 is characterized by distinctive facial features, developmental delays, intellectual disabilities, and other health problems.

Test Components and Price

Test Name: KDM6A Gene Kabuki Syndrome Type 2 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition and Report Delivery

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method and Test Type

Method: NGS Technology

Test Type: Neurological Disorders

Doctor and Test Department

Doctor: Neurologist

Test Department: Genetics

Pre Test Information

Before undergoing the KDM6A Gene Kabuki Syndrome Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by KDM6A Gene Kabuki Syndrome Type 2.

Test Details

The KDM6A gene is associated with Kabuki Syndrome Type 2. To identify mutations or variations in the KDM6A gene that may be causing the disorder, we utilize NGS (Next-Generation Sequencing) genetic testing. This advanced sequencing technology allows us to analyze multiple genes simultaneously.

To perform the test, we require a blood or saliva sample from the individual suspected of having Kabuki Syndrome Type 2. The DNA from the sample is then sequenced using NGS technology to identify any mutations or variations in the KDM6A gene.

NGS genetic testing for Kabuki Syndrome Type 2 serves several purposes. It can confirm a diagnosis, provide information about the specific genetic cause of the disorder, assist in genetic counseling and family planning, and guide medical management and treatment options.

Test Name KDM6A Gene Kabuki syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KDM6A Gene Kabuki syndrome type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KDM6A Gene Kabuki syndrome type 2
Test Details

The KDM6A gene is associated with Kabuki syndrome type 2, which is a rare genetic disorder characterized by distinctive facial features, developmental delays, intellectual disabilities, and other health problems.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of Kabuki syndrome type 2, NGS genetic testing can be used to identify mutations or variations in the KDM6A gene that may be causing the disorder.

This type of genetic testing is typically performed by obtaining a blood or saliva sample from the individual suspected of having Kabuki syndrome type 2. The DNA from the sample is then sequenced using NGS technology to identify any mutations or variations in the KDM6A gene.

NGS genetic testing for Kabuki syndrome type 2 can help confirm a diagnosis, provide information about the specific genetic cause of the disorder, and assist in genetic counseling and family planning. It can also help guide medical management and treatment options for individuals with the condition.